Diagnostic Approach for RLQ Pain with Adnexal Mass and Lymphadenopathy
Given the initial ultrasound findings of a right adnexal mass with right lymphadenopathy, the next step is MRI pelvis with and without IV contrast to characterize the mass and assess for malignancy, as this combination of findings raises significant concern for ovarian malignancy. 1
Immediate Considerations
The presence of lymphadenopathy alongside an adnexal mass is a red flag that substantially elevates concern for malignancy. This is not a typical presentation of benign pathology and requires aggressive diagnostic workup.
Critical First Steps
Rule out pregnancy in reproductive-age women with beta-hCG testing before proceeding with contrast-enhanced imaging 2
Obtain CA-125 level to assist in risk stratification, though recognize this biomarker has limitations:
- Elevated in many benign conditions (endometriosis, fibroids, pelvic inflammatory disease)
- Substantial overlap between pre- and postmenopausal values
- Should not be used alone to differentiate benign from malignant 3
Imaging Algorithm
Next Imaging Study: MRI Pelvis
MRI pelvis without and with IV contrast is the appropriate next step for characterizing an adnexal mass that appears suspicious for malignancy on initial ultrasound 1. The 2024 ACR Appropriateness Criteria specifically designate this as "usually appropriate" for indeterminate or suspicious adnexal masses.
Why MRI over repeat ultrasound:
- MRI-ADNEX scoring system demonstrates 91% sensitivity and 95% specificity for distinguishing benign from malignant masses 4
- Superior tissue characterization with diffusion-weighted imaging (DWI) and dynamic contrast enhancement
- Better assessment of disease extent beyond the ovary, particularly with lymphadenopathy present
- Can identify mural nodules with restricted diffusion (lower ADC values) indicating malignancy 1
Role of CT
The ACR guidelines note that CT pelvis without and with IV contrast is controversial for this indication 1. However, if MRI is unavailable or contraindicated, CT may be considered to:
- Assess extent of disease if malignancy is suspected
- Evaluate lymphadenopathy more comprehensively
- Identify alternative diagnoses 5
Key Imaging Features Suggesting Malignancy
When reviewing imaging, look for:
- Mass characteristics: Size >10 cm, solid components, complex architecture
- Vascular features: High color flow on Doppler, enhancing mural nodules
- Morphology: Papillary projections, thick septations, irregularity, bilaterality 3, 2
- Diffusion restriction: Low ADC values on DWI sequences indicate malignancy 1
- Lymphadenopathy: Already present in this case, highly concerning
Clinical Assessment Priorities
Focus history on ovarian cancer symptoms:
- Abdominal pain, bloating, increased abdominal size
- Difficulty eating or early satiety
- Symptoms occurring >12 times per month for <1 year 3
Family history is critical:
- Ovarian cancer, breast cancer, Lynch syndrome, or other hereditary cancer syndromes increase malignancy risk 2
Common Pitfalls to Avoid
Do not rely on negative pelvic examination - it has low sensitivity for detecting adnexal masses; symptomatic patients require imaging regardless 3
Do not perform serial ultrasound for surveillance when lymphadenopathy is present - this finding demands immediate characterization, not observation
Do not delay gynecologic oncology consultation if imaging confirms high-risk features - masses >6 cm with suspicious characteristics or lymphadenopathy warrant specialist involvement 3, 2
Management Pathway
If MRI confirms high malignancy risk:
- Immediate referral to gynecologic oncology
- Surgical staging and cytoreduction by a specialist improves outcomes
If MRI shows indeterminate features:
- Consider multimodal risk assessment tools (Risk of Malignancy Index combining ultrasound, CA-125, and menopausal status) 2
- Close gynecology follow-up with repeat imaging in 6-12 weeks only if malignancy risk is truly low
The presence of lymphadenopathy makes expectant management inappropriate - this patient requires definitive tissue diagnosis through surgical consultation.